A broad range of implant diameters and lengths for the treatment of in-stent restenotic peripheral and central lesions* in patients with AV grafts and AV fistulae
Small incremental stent graft lengths to help maintain venous real estate and cannulation area
Minimal shortening and radiopaque markers aid in excellent placement accuracy
Minimal shortening and radiopaque markers
aid in excellent placement accuracy
The multi-braided delivery system with a tipless
inner catheter designed to reduce the risk of
catheter entanglement during withdrawal
Dual layer ePTFE encapsulation demonstrated a
significant reduction at 90 days in the incidence
of in-stent restenosis compared to PTA**
Proprietary bioactive carbon impregnation
designed to reduce early stage platelet adhesion
Flexible implant that demonstrated kink
resistance after placement in tortuous AV†
access lesions presenting with ISR†† or nonstented lesions in patients with AV grafts
Prescriptive Information
Prior to use, please see the complete “Instructions for Use” for more information on Indications,
Contraindications, Warnings, Precautions, Adverse Events and Operator’s Instructions.
Indications
The FLUENCY® PLUS Endovascular Stent Graft is indicated for use in the treatment of in-stent restenosis in the
venous outflow of hemodialysis patients dialyzing by either an arteriovenous (AV) fistula or AV graft and for
the treatment of stenosis in the venous outflow of hemodialysis patients dialyzing by an AV graft.